Recent manuscripts
Archive
Aims and Scope
Editorial Board
Open Access
Indexing
Contact us
Authorship & COI
Principles of Transparency Checklist
Publication Ethics
Crossmark
Data Policies
Supporting Diversity
Instructions to authors (PDF)
Manuscript Types
Manuscript Formatting
Professional Editing Service
How to submit
Special Publications & Reprints
Preprints
TID on Twitter
RESEARCH PAPER
Impact of connecting tuberculosis directly observed therapy short-course with smoking cessation on health-related quality of life
| 1 | College of Pharmacy, Qatar University, P.O. Box 2713, Doha, Qatar |
| 2 | Faculty
of Pharmacy, International Islamic University Malaysia, 25200 Kuantan,
Malaysia |
| 3 | Institute for Health Management, Ministry of Health, 59000 Kuala
Lumpur, Malaysia |
| 4 | Institute for Respiratory Medicine, 53000 Wilayah
Persekutuan, Kuala Lumpur, Malaysia |
| 5 | Faculty of Pharmacy, Universiti
Technology Mara, 5600 Puncak Alam, Malaysia |
| 6 | School of Pharmaceutical
Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia |
CORRESPONDING AUTHOR
Submission date: 2011-11-03
Acceptance date: 2012-02-28
Publication date: 2012-02-28
Tobacco Induced Diseases 2012;10(February):2
KEYWORDS
ABSTRACT
Background:
With evolving evidence of association between tuberculosis (TB) and tobacco smoking, recommendations for the inclusion of tobacco cessation interventions in TB care are becoming increasingly important and more widely disseminated. Connecting TB and tobacco cessation interventions has been strongly advocated as this may yield better outcomes. However, no study has documented the impact of such connection on health-related quality of life (HRQoL). The objective of this study was to document the impact of an integrated TB directly observed therapy short-course (DOTS) plus smoking cessation intervention (SCI) on HRQoL.
Methods:
This was a multi-centered non-randomized controlled study involving 120 TB patients who were current smokers at the time of TB diagnosis in Malaysia. Patients were assigned to either of two groups: the usual TB-DOTS plus SCI (SCIDOTS group) or the usual TB-DOTS only (DOTS group). The effect of the novel strategy on HRQoL was measured using EQ-5D questionnaire. Two-way repeated measure ANOVA was used to examine the effects.
Results:
When compared, participants who received the integrated intervention had a better HRQoL than those who received the usual TB care. The SCIDOTS group had a significantly greater increase in EQ-5D utility score than the DOTS group during 6 months follow-up (mean ± SD = 0.98 ± 0.08 vs. 0.91 ± 0.14, p = 0.006). Similarly, the mean scores for EQ-VAS showed a consistently similar trend as the EQ-5D indices, with the scores increasing over the course of TB treatment. Furthermore, for the EQ-VAS, there were significant main effects for group [F (1, 84) = 4.91, p = 0.029, h2 = 0.06], time [F (2, 168) = 139.50, p = < 0.001, h2 = 0.62] and group x time interaction [F (2, 168) = 13.89, p = < 0.001, h2 = 0.14].
Conclusions:
This study supports the evidence that an integrated TB-tobacco treatment strategy could potentially improve overall quality of life outcomes among TB patients who are smokers.
With evolving evidence of association between tuberculosis (TB) and tobacco smoking, recommendations for the inclusion of tobacco cessation interventions in TB care are becoming increasingly important and more widely disseminated. Connecting TB and tobacco cessation interventions has been strongly advocated as this may yield better outcomes. However, no study has documented the impact of such connection on health-related quality of life (HRQoL). The objective of this study was to document the impact of an integrated TB directly observed therapy short-course (DOTS) plus smoking cessation intervention (SCI) on HRQoL.
Methods:
This was a multi-centered non-randomized controlled study involving 120 TB patients who were current smokers at the time of TB diagnosis in Malaysia. Patients were assigned to either of two groups: the usual TB-DOTS plus SCI (SCIDOTS group) or the usual TB-DOTS only (DOTS group). The effect of the novel strategy on HRQoL was measured using EQ-5D questionnaire. Two-way repeated measure ANOVA was used to examine the effects.
Results:
When compared, participants who received the integrated intervention had a better HRQoL than those who received the usual TB care. The SCIDOTS group had a significantly greater increase in EQ-5D utility score than the DOTS group during 6 months follow-up (mean ± SD = 0.98 ± 0.08 vs. 0.91 ± 0.14, p = 0.006). Similarly, the mean scores for EQ-VAS showed a consistently similar trend as the EQ-5D indices, with the scores increasing over the course of TB treatment. Furthermore, for the EQ-VAS, there were significant main effects for group [F (1, 84) = 4.91, p = 0.029, h2 = 0.06], time [F (2, 168) = 139.50, p = < 0.001, h2 = 0.62] and group x time interaction [F (2, 168) = 13.89, p = < 0.001, h2 = 0.14].
Conclusions:
This study supports the evidence that an integrated TB-tobacco treatment strategy could potentially improve overall quality of life outcomes among TB patients who are smokers.
REFERENCES (42)
1.
Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR: Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med. 2007, 167 (4): 335-342. 10.1001/archinte.167.4.335.
2.
Lin HH, Ezzati M, Murray M: Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med. 2007, 4 (1): e20-10.1371/journal.pmed.0040020.
3.
Slama K, Chiang CY, Enarson DA, Hassmiller K, Fanning A, Gupta P, Ray C: Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis. 2007, 11 (10): 1049-1061.
4.
Siddiqi K, Lee AC: An integrated approach to treat tobacco addiction in countries with high tuberculosis incidence. Trop Med Int Health. 2009, 14 (4): 420-428. 10.1111/j.1365-3156.2009.02238.x.
5.
Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, Selvakumar N, Ganapathy S, Charles N, Rajamma J, et al: Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis. 2002, 6 (9): 780-788.
6.
Chang KC, Leung CC, Tam CM: Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong. Int J Tuberc Lung Dis. 2004, 8 (12): 1492-1498.
7.
Thomas A, Gopi PG, Santha T, Chandrasekaran V, Subramani R, Selvakumar N, Eusuff SI, Sadacharam K, Narayanan PR: Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis. 2005, 9 (5): 556-561.
8.
d'Arc Lyra Batista J, de Fatima Pessoa Militao de Albuquerque M, De Alencar Ximenes RA, Rodrigues LC: Smoking increases the risk of relapse after successful tuberculosis treatment. Int J Epidemiol. 2008, 37 (4): 841-851.
9.
Yach D: Partnering for better lung health: improving tobacco and tuberculosis control. Int J Tuberc Lung Dis. 2000, 4 (8): 693-697.
10.
Schneider NK, Novotny TE: Addressing smoking cessation in tuberculosis control. Bull World Health Organ. 2007, 85 (10): 820-821. 10.2471/BLT.07.034797.
11.
Novotny TE: Smoking cessation and tuberculosis: connecting the DOTS. Int J Tuberc Lung Dis. 2008, 12 (10): 1103.
12.
Awaisu A, Nik Mohamed MH, Abd Aziz N, Syed Sulaiman SA, Mohamad Noordin N, Muttalif AR, Ahmad Mahayiddin A: Tobacco use prevalence, knowledge, and attitudes among newly diagnosed tuberculosis patients in Penang State and Wilayah Persekutuan Kuala Lumpur, Malaysia. Tob Induc Dis. 2010, 8 (1): 3-10.1186/1617-9625-8-3.
13.
Awaisu A, Mohamed MHN, Noordin NM, Aziz NA, Sulaiman SAS, Muttalif AR, Mahayiddin AA: Potential impact of a pilot training program on smoking cessation intervention for tuberculosis DOTS providers in Malaysia. J Public Health. 2010, 18 (3): 279-288. 10.1007/s10389-009-0302-5.
14.
Slama K, Chiang CY, Enarson DA: Introducing brief advice in tuberculosis services. Int J Tuberc Lung Dis. 2007, 11 (5): 496-499.
15.
Slama K, Chiang CY, Enarson DA: Tobacco cessation and brief advice. Int J Tuberc Lung Dis. 2007, 11 (6): 612-616.
16.
El Sony A, Slama K, Salieh M, Elhaj H, Adam K, Hassan A, Enarson DA: Feasibility of brief tobacco cessation advice for tuberculosis patients: a study from Sudan. Int J Tuberc Lung Dis. 2007, 11 (2): 150-155.
17.
Slama K, Chiang CY, Enarson DA: An educational series about tobacco cessation interventions for tuberculosis patients: what about other patients?. Int J Tuberc Lung Dis. 2007, 11 (3): 244.
18.
Slama K, Chiang CY, Enarson DA: Helping patients to stop smoking. Int J Tuberc Lung Dis. 2007, 11 (7): 733-738.
19.
Chiang CY, Slama K, Enarson DA: Tobacco use and tobacco control. Int J Tuberc Lung Dis. 2007, 11 (4): 381-385.
20.
Chiang CY, Slama K, Enarson DA: Associations between tobacco and tuberculosis. Int J Tuberc Lung Dis. 2007, 11 (3): 258-262.
21.
Enarson DA, Slama K, Chiang CY: Providing and monitoring quality service for smoking cessation in tuberculosis care. Int J Tuberc Lung Dis. 2007, 11 (8): 838-847.
22.
WHO, IUATLD: A WHO/The Union Monograph on TB and Tobacco Control. Joining Efforts to Control Two Related Global Epidemics. 2007, Geneva: World Health Organization & International Union Against Tuberculosis and Lung Disease.
23.
Tobacco Cessation Interventions for Tuberculosis Patients A Guide for Low-Income Countries. Edited by: Slama K, Chiang CY, Enarson DA. 2008, Paris: International Union Against Tuberculosis and Lung Disease.
24.
WHO: Tuberculosis and Tobacco: a strong association. 2009, Geneva: World Health Organization.
25.
Quality of Life and Pharmacoeconomics in Clinical Trials. Edited by: Spilker B. 1996, Philadelphia: Lippincott-Raven.
26.
Dion MJ, Tousignant P, Bourbeau J, Menzies D, Schwartzman K: Feasibility and reliability of health-related quality of life measurements among tuberculosis patients. Qual Life Res. 2004, 13 (3): 653-665.
27.
DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS: The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol. 1991, 59 (2): 295-304.
28.
Brooks R: EuroQol: the current state of play. Health Policy. 1996, 37 (1): 53-72. 10.1016/0168-8510(96)00822-6.
29.
The EuroQol Group: EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990, 16 (3): 199-208.
30.
Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001, 33 (5): 337-343. 10.3109/07853890109002087.
31.
Gudex C, Dolan P, Kind P, Williams A: Health state valuations from the general public using the visual analogue scale. Qual Life Res. 1996, 5 (6): 521-531. 10.1007/BF00439226.
32.
Dolan P, Gudex C, Kind P, Williams A: A Social Tariff for EuroQol: Results from a UK General Population Survey. 1995, York: The University of York.
33.
Awaisu A, Nik Mohamed MH, Mohamad Noordin NM, Abd Aziz N, Syed Sulaiman SA, Muttalif RA, Ahmed Mahayiddin MA: The SCIDOTS Project: Evidence of benefits of an integrated tobacco cessation intervention in tuberculosis care on treatment outcomes. Subst Abuse Treat, Prev, Pol. 2011, 6: 26.
34.
Lavigne M, Rocher I, Steensma C, Brassard P: The impact of smoking on adherence to treatment for latent tuberculosis infection. BMC Publ Health. 2006, 6: 66-10.1186/1471-2458-6-66.
35.
Guo N, Marra F, Marra CA: Measuring health-related quality of life in tuberculosis: a systematic review. Health Qual Life Outcomes. 2009, 7: 14-10.1186/1477-7525-7-14.
36.
Rajeswari R, Muniyandi M, Balasubramanian R, Narayanan PR: Perceptions of tuberculosis patients about their physical, mental and social well-being: a field report from south India. Soc Sci Med. 2005, 60 (8): 1845-1853. 10.1016/j.socscimed.2004.08.024.
37.
Marra CA, Marra F, Cox VC, Palepu A, Fitzgerald JM: Factors influencing quality of life in patients with active tuberculosis. Health Qual Life Outcomes. 2004, 2: 58-10.1186/1477-7525-2-58.
38.
Chamla D: The assessment of patients' health-related quality of life during tuberculosis treatment in Wuhan, China. Int J Tuberc Lung Dis. 2004, 8 (9): 1100-1106.
39.
Wang Y, Lii J, Lu F: Measuring and assessing the quality of life of patients with pulmonary tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi. 1998, 21 (12): 720-723.
40.
Dhingra VK, Rajpal S: Health related quality of life (HRQL) scoring (DR-12 score) in tuberculosis-additional evaluative tool under DOTS. J Commun Dis. 2005, 37 (4): 261-268.
41.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 1994, Washington: American Psychiatric Association, 4.
42.
West R, Ussher M, Evans M, Rashid M: Assessing DSM-IV nicotine withdrawal symptoms: a comparison and evaluation of five different scales. Psychopharmacology (Berl). 2006, 184 (3-4): 619-627. 10.1007/s00213-005-0216-z.
CITATIONS (20):
1.
Assessment of the influence of direct tobacco smoke on infection and active TB management
Neus Altet, Irene Latorre, María Ángeles Jiménez-Fuentes, José Maldonado, Israel Molina, Yoel González-Díaz, Celia Milà, Esther García-García, Beatriz Muriel, Raquel Villar-Hernández, Maisem Laabei, Andromeda-Celeste Gómez, Pere Godoy, Maria Luiza de Souza-Galvão, Segismundo Solano, Carlos A. Jiménez-Ruiz, Jose Domínguez, Richard van Zyl-Smit
PLOS ONE
Neus Altet, Irene Latorre, María Ángeles Jiménez-Fuentes, José Maldonado, Israel Molina, Yoel González-Díaz, Celia Milà, Esther García-García, Beatriz Muriel, Raquel Villar-Hernández, Maisem Laabei, Andromeda-Celeste Gómez, Pere Godoy, Maria Luiza de Souza-Galvão, Segismundo Solano, Carlos A. Jiménez-Ruiz, Jose Domínguez, Richard van Zyl-Smit
PLOS ONE
2.
Examining the social status, risk factors and lifestyle changes of tuberculosis patients in Sri Lanka during the treatment period: a cross-sectional study
Madapathage Gayan Buddhika Senanayake, Sumudu Indika Wickramasinghe, Sudath Samaraweera, Pubudu De Silva, Sisira Edirippulige
Multidisciplinary Respiratory Medicine
Madapathage Gayan Buddhika Senanayake, Sumudu Indika Wickramasinghe, Sudath Samaraweera, Pubudu De Silva, Sisira Edirippulige
Multidisciplinary Respiratory Medicine
3.
Smoked and smokeless tobacco use among pulmonary tuberculosis patients under RNTCP in urban Puducherry, India
Veerakumar Arumugam Mariappan, Swaroop Kumar Sahu, Sonali Sarkar, Shivanand Kattimani, Govindarajan Soundappan
Indian Journal of Tuberculosis
Veerakumar Arumugam Mariappan, Swaroop Kumar Sahu, Sonali Sarkar, Shivanand Kattimani, Govindarajan Soundappan
Indian Journal of Tuberculosis
4.
Cost-effectiveness of Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the Republic of Korea
Hae-Young Park, Hye-min Ku, Hyun-Soon Sohn, Hae-Sook Seo, Hyun Yung Lee, Kyung Hwa Lim, Jin-Won Kwon
Clinical Therapeutics
Hae-Young Park, Hye-min Ku, Hyun-Soon Sohn, Hae-Sook Seo, Hyun Yung Lee, Kyung Hwa Lim, Jin-Won Kwon
Clinical Therapeutics
5.
Smoking on Treatment Outcomes Among Tuberculosis Patients
Amer H. Khan, Raja A. Aftab, Mohammad Israr, Ayesha Khan, Tahir M. Khan
The American Journal of the Medical Sciences
Amer H. Khan, Raja A. Aftab, Mohammad Israr, Ayesha Khan, Tahir M. Khan
The American Journal of the Medical Sciences
6.
Health-related quality of life and its association with medication adherence in active pulmonary tuberculosis– a systematic review of global literature with focus on South Africa
Tanja Kastien-Hilka, Ahmed Abulfathi, Bernd Rosenkranz, Bryan Bennett, Matthias Schwenkglenks, Edina Sinanovic
Health and Quality of Life Outcomes
Tanja Kastien-Hilka, Ahmed Abulfathi, Bernd Rosenkranz, Bryan Bennett, Matthias Schwenkglenks, Edina Sinanovic
Health and Quality of Life Outcomes
8.
Smoking cessation interventions for pulmonary tuberculosis treatment outcomes
Kathiresan Jeyashree, Soundappan Kathirvel, Hemant D Shewade, Harpreet Kaur, Sonu Goel
Cochrane Database of Systematic Reviews
Kathiresan Jeyashree, Soundappan Kathirvel, Hemant D Shewade, Harpreet Kaur, Sonu Goel
Cochrane Database of Systematic Reviews
9.
Health-related quality of life in South African patients with pulmonary tuberculosis
Tanja Kastien-Hilka, Bernd Rosenkranz, Edina Sinanovic, Bryan Bennett, Matthias Schwenkglenks, Ashutosh Nath Aggarwal
PLOS ONE
Tanja Kastien-Hilka, Bernd Rosenkranz, Edina Sinanovic, Bryan Bennett, Matthias Schwenkglenks, Ashutosh Nath Aggarwal
PLOS ONE
10.
A cognitive behavioral smoking abstinence intervention for adults with chronic pain: A randomized controlled pilot trial
W. Michael Hooten, Cynthia O. Townsend, J. Taylor Hays, Kaye L. Ebnet, Thomas R. Gauvin, Jessica M. Gehin, Heidi J. Laures, Christi A. Patten, David O. Warner
Addictive Behaviors
W. Michael Hooten, Cynthia O. Townsend, J. Taylor Hays, Kaye L. Ebnet, Thomas R. Gauvin, Jessica M. Gehin, Heidi J. Laures, Christi A. Patten, David O. Warner
Addictive Behaviors
11.
Health-related quality of life as a predictor of tuberculosis treatment outcomes in Iraq
Juman Abdulelah Dujaili, Syed Azhar Syed Sulaiman, Mohamed Azmi Hassali, Ahmed Awaisu, Ali Qais Blebil, Jason M. Bredle
International Journal of Infectious Diseases
Juman Abdulelah Dujaili, Syed Azhar Syed Sulaiman, Mohamed Azmi Hassali, Ahmed Awaisu, Ali Qais Blebil, Jason M. Bredle
International Journal of Infectious Diseases
12.
The potential impact and cost-effectiveness of tobacco reduction strategies for tuberculosis prevention in Canadian Inuit communities
Dieynaba S. N’Diaye, Ntwali Placide Nsengiyumva, Aashna Uppal, Olivia Oxlade, Gonzalo G. Alvarez, Kevin Schwartzman
BMC Medicine
Dieynaba S. N’Diaye, Ntwali Placide Nsengiyumva, Aashna Uppal, Olivia Oxlade, Gonzalo G. Alvarez, Kevin Schwartzman
BMC Medicine
13.
Benefit of treatment of latent tuberculosis infection in individual patients
Claudia C. Dobler, Andrew Martin, Guy B. Marks
European Respiratory Journal
Claudia C. Dobler, Andrew Martin, Guy B. Marks
European Respiratory Journal
14.
Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit
Carlos A. Jiménez-Ruiz, Stefan Andreas, Keir E. Lewis, Philip Tonnesen, C.P. van Schayck, Peter Hajek, Serena Tonstad, Bertrand Dautzenberg, Monica Fletcher, Sarah Masefield, Pippa Powell, Thomas Hering, Stefano Nardini, Thomy Tonia, Christina Gratziou
European Respiratory Journal
Carlos A. Jiménez-Ruiz, Stefan Andreas, Keir E. Lewis, Philip Tonnesen, C.P. van Schayck, Peter Hajek, Serena Tonstad, Bertrand Dautzenberg, Monica Fletcher, Sarah Masefield, Pippa Powell, Thomas Hering, Stefano Nardini, Thomy Tonia, Christina Gratziou
European Respiratory Journal
15.
The Effect of Treatment during A Haze/Post-Haze Year on Subsequent Respiratory Morbidity Status among Successful Treatment Tuberculosis Cases
Suyanto Suyanto, Alan Geater, Virasakdi Chongsuvivatwong
International Journal of Environmental Research and Public Health
Suyanto Suyanto, Alan Geater, Virasakdi Chongsuvivatwong
International Journal of Environmental Research and Public Health
16.
Tobacco use and nicotine dependence among newly diagnosed pulmonary tuberculosis patients in Ballabgarh tuberculosis unit, Haryana
Rakesh Kumar, Shashi Kant, Ankit Chandra, Anand Krishnan
Journal of Family Medicine and Primary Care
Rakesh Kumar, Shashi Kant, Ankit Chandra, Anand Krishnan
Journal of Family Medicine and Primary Care
17.
Design, development and randomised controlled trial of a smartphone application, ‘QinTB’, for smoking cessation in tuberculosis patients: study protocol
Haoxiang Lin, Yan Lin, Yunting Zheng, Zhao Liu, Chun Chang
BMJ Open
Haoxiang Lin, Yan Lin, Yunting Zheng, Zhao Liu, Chun Chang
BMJ Open
18.
The Effect of Self-Care Education on the Quality of Life in Patients with Pulmonary Tuberculosis
Maryam Abiz, Hasan Robabi, Alireza Salar, Farshid Saeedinezhad
Medical - Surgical Nursing Journal
Maryam Abiz, Hasan Robabi, Alireza Salar, Farshid Saeedinezhad
Medical - Surgical Nursing Journal
20.
Health-Related Quality of Life Based on EQ-5D Utility Score in Patients With Tuberculosis: A Systematic Review
Hae-Young Park, Hyo-Bin Cheon, Sun Choi, Jin-Won Kwon
Frontiers in Pharmacology
Hae-Young Park, Hyo-Bin Cheon, Sun Choi, Jin-Won Kwon
Frontiers in Pharmacology
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.